☆ 4.4 Letter

Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients

SCHIZOPHRENIA RESEARCH (2018)

Get Full Text
Add to Collection

Journal

SCHIZOPHRENIA RESEARCH
Volume 199, Issue -, Pages 438-441

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.schres.2018.03.029

Keywords

Schizophrenia; Sphingolipids; Cerebrospinal fluid; Biomarkers; Demyelination

Categories

Psychiatry

Funding

  1. Swedish Medical Research Council [2009-7053, 2013-2838, 523-2014-3467, 2015-02836]
  2. Thematic Center in Inflammation at the Karolinska Institute, the Vinnova (CIDaT)
  3. Swedish Brain Foundation
  4. Ahlen-siftelsen
  5. Petrus och Augusta Hedlunds Stiftelse
  6. Torsten Soderbergs Stiftelse
  7. AstraZeneca-Karolinska Institutet Joint Research Program in Translational Science
  8. Soderbergs Konigska Stiftelse
  9. Stockholm County Council (ALF)
  10. Stockholm County Council (PPG)
  11. Karolinska Institutet
  12. Swedish Research Council [2015-02836] Funding Source: Swedish Research Council

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.